Compare

AngloGold Ashanti vs Franco-Nevada

MonkScore ranges and fundamentals, side by side

Key facts

AngloGold Ashanti and Franco-Nevada: key facts

  • In fiscal 2025, AngloGold Ashanti plc reported revenue of $9.9B and net income of $2.6B.
  • In fiscal 2025, Franco-Nevada Corporation reported revenue of $1.8B and net income of $1.1B.
  • AngloGold Ashanti plc's revenue grew 25.2% a year from fiscal 2021 to fiscal 2025.
  • Franco-Nevada Corporation's revenue grew 8.8% a year from fiscal 2021 to fiscal 2025.
  • AngloGold Ashanti plc's free cash flow was positive in 4 of the 5 fiscal years from 2021 to 2025.
  • Franco-Nevada Corporation's free cash flow was positive in 4 of the 5 fiscal years from 2021 to 2025.
  • In the twelve months to 30 June 2026, AngloGold Ashanti plc reported revenue of $11.8B and net income of $3.8B.
  • In the twelve months to 30 June 2026, Franco-Nevada Corporation reported revenue of $2.3B and net income of $1.5B.

Side by side

AngloGold Ashanti and Franco-Nevada, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureAngloGold Ashanti plcNYSE:AUFranco-Nevada CorporationNYSE:FNV
MonkScore
MonkScore range90–100as of November 202680–90as of November 2026
Sector rank50 of 621 in Basic Materials66 of 619 in Basic Materials
How this score is madeDisclaimer
Profile
SectorBasic MaterialsBasic Materials
IndustryGoldGold
Latest fiscal year
Revenue$9.9BFY 2025$1.8BFY 2025
Net income$2.6BFY 2025$1.1BFY 2025
Free cash flow$3.1BFY 2025-$703.0MFY 2025
Operating cash flow$4.7BFY 2025$1.5BFY 2025
Total debt$2.4BFY 2025$8.6MFY 2025
Cash$2.9BFY 2025$433.1MFY 2025
Last 12 months
Revenue$11.8Bto 30 June 2026$2.3Bto 30 June 2026
Net income$3.8Bto 30 June 2026$1.5Bto 30 June 2026
Free cash flow$4.2Bto 30 June 2026$891.4Mto 30 June 2026
Operating cash flow$6.1Bto 30 June 2026$1.8Bto 30 June 2026
Total debt$1.8Bto 30 June 2026$0.0to 30 June 2026
Cash$2.8Bto 30 June 2026$1.0Bto 30 June 2026

MonkStreet provides research, not investment advice.